The novel atypical antipsychotic olanzapine, but not the CCK-B antagonist LY288513, blocks apomorphine-induced disruption of pre-pulse inhibition.

Saved in:
Bibliographic Details
Title: The novel atypical antipsychotic olanzapine, but not the CCK-B antagonist LY288513, blocks apomorphine-induced disruption of pre-pulse inhibition.
Authors: Rasmussen K; Lilly Research Laboratories, Eli Lilly and Co., IN 46285, USA. rasmussen_kurt@lilly.com, Gates MR, Burger JE, Czachura JF
Source: Neuroscience letters [Neurosci Lett] 1997 Jan 24; Vol. 222 (1), pp. 61-4.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Scientific Publishers Ireland Country of Publication: Ireland NLM ID: 7600130 Publication Model: Print Cited Medium: Print ISSN: 0304-3940 (Print) Linking ISSN: 03043940 NLM ISO Abbreviation: Neurosci Lett Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0304-3940
DOI:10.1016/s0304-3940(97)13346-8